A detailed history of Gallagher Benefit Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Gallagher Benefit Services, Inc. holds 2,076 shares of ABBV stock, worth $364,504. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,076
Holding current value
$364,504
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 27, 2023

BUY
$138.31 - $165.87 $287,131 - $344,346
2,076 New
2,076 $336 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gallagher Benefit Services, Inc. Portfolio

Follow Gallagher Benefit Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gallagher Benefit Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gallagher Benefit Services, Inc. with notifications on news.